Notes (1/5)
Page 5
1. AXA sold its remaining stake in Equitable Holdings, Inc. (“EQH”), excluding 44,162,500 shares of common stock of EQH, primarily related to the EQH shares to be delivered on redemption
of the AXA S.A. bonds mandatorily exchangeable into EQH shares, maturing in May 2021.
2. Based on FY19 pre-tax underlying earnings, excluding Equitable Holdings Inc. and AXA SA and other central holdings.
3. 14 disposals include UK Life & Savings (2016), Serbia operations (2016), AXA Bank Hungary (2016), Bluefin in UK (2016), Romania operations (2017), German Pro Bav (2018), Equitable
Holdings Inc. (2019), Ukraine operations (2019), Central and Eastern European operations (2020), Architas UK (2020), as well as the potential disposals of AXA Bank Belgium, Bharti AXA
General Insurance in India, AXA Bank Germany and Gulf operations, which have been signed but not yet been completed. The completion of these transactions is subject to customary
closing conditions, including the receipt of regulatory approvals.
4. Estimation for full year 2020 based on experience to-date.
Page 6
1. Underlying Earnings (“UE”), Underlying Earnings per share (“UEPS”) and Adjusted Return on Equity (“AROE”) are APMs. For further information, please refer to the reconciliation of these
non-GAAP financial measures to the financial statements and to their definition in the Glossary, which are provided in the Half-Year 2020 Financial Report (respectively, on pages 19-20, 26
and 60 to 67).
2. Free cash flows.
3. The Solvency II ratio is estimated primarily using AXA’s internal model calibrated based on an adverse 1/200 years shock. It includes a theoretical amount for dividends accrued for the
first nine months of 2020, based on the full year dividend of Euro 1.43 per share initially proposed by the Board for FY19. Dividends are proposed by the Board, at its discretion based on a
variety of factors described in AXA’s 2019 Universal Registration Document, and then submitted to AXA’s shareholders for approval. This estimate should not be considered in any way to
be an indication of the actual dividend amount, if any, for the 2020 financial year. For further information on AXA’s internal model and Solvency II dis closures, please refer to AXA Group’s
SFCR as of December 31, 2019, available on AXA’s website (www.axa.com). In compliance with the decision from AXA’s lead supervisor (the ACPR) from January 1, 2019, entities that were
part of the XL Group (“XL entities”) have been fully consolidated for Solvency II purposes (as per the consolidation-based method set forth in the Solvency II Directive) and their
contribution to the Group’s solvency capital requirement has been calculated using the Solvency II standard formula. Subject to the prior approval of the ACPR, the Group intends to
extend its Internal Model to XL entities as soon as December 31, 2020.
Page 7
1. Gross written premiums. As of FY19.
2. 10% p.a. growth refers to the period 2020E-2023E and €1bn GWP is a target by 2023.
3. Based on earnings before interest and taxes (EBIT) as of FY20E.
4. For the period 2020E-2023E.
5. As of September 2020.
50 | AXA Group Investor Day | December 1, 2020
Back to agenda